Sertoli-Leydig cell ovarian tumour: a rare cause of virilisation and androgenic alopecia

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Sertoli-Leydig cell tumours (SLCTs) represent a rare cause of hyperandrogenic state. SLCTs are sex cord ovarian neoplasms, accounting for <0.2% of all ovarian tumours. Most of the sex cord-stromal tumours have a benign clinical course, with 10%-20% of them at risk of aggressive course. We report a case of a woman in her 30s who presented with androgenic alopecia, virilisation and secondary amenorrhoea. The evaluation revealed an extremely high testosterone level. Imaging for the localisation of source of excess testosterone with contrast-enhanced CT of the abdomen revealed a right ovarian mass. Hence, a diagnosis of testosterone-secreting ovarian tumour was considered. The patient underwent right salphingo-oophorectomy, and histopathology was reported as Sertoli cell tumour. Postoperatively, there was normalisation of serum testosterone levels with decrease in virilisation and resumption of spontaneous menstrual cycles. The patient conceived spontaneously after 2 months of surgery.

Original languageEnglish
Article numbere249324
JournalBMJ Case Reports
Issue number8
Publication statusPublished - 25-08-2022

All Science Journal Classification (ASJC) codes

  • General Medicine


Dive into the research topics of 'Sertoli-Leydig cell ovarian tumour: a rare cause of virilisation and androgenic alopecia'. Together they form a unique fingerprint.

Cite this